Yale Study Links Genetics and Blood Pressure Control in Stroke Survivors
Stroke survivors face an increased risk of suffering a second stroke and developing cognitive disabilities as a result. Evidence indicates that hypertension plays a significant role in this comorbidity, and yet, only 60% of stroke survivors have their blood pressure under control. A Yale-led study studies the link between elevated genetic predisposition to hypertension and more-difficult-to-control blood pressure.
Symposium Highlights Importance of Biomedical Imaging for Understanding Neurological Disease
A Neuroimaging in Neurological Disorders and Diseases Symposium at Yale highlighted how imaging technology can enhance basic neuroscience research to help scientists better understand neurological diseases.
Yale Wins Catalyst Award for Transformation in Graduate Medical Education
A new Yale learning initiative, Clinical Learning Environment Optimizing Uptake Training (CLOUT), is one of the six recipients of the Josiah Macy Jr. Foundation Catalyst Awards for Transformation in Graduate Medical Education (GME).
How Brain Regions Involved in Wakeful Rest May Play a Role in the Risk for Alzheimer’s Disease
Daydreaming puts the brain in a state of wakeful rest, allowing the connection of brain regions known as the Default Mode Network (DMN) to interact. The DMN is now a topic of investigation for researchers trying to understand why women are at a higher risk for Alzheimer's Disease than men.
Study Identifies Neuronal Basis of Impaired Consciousness in Absence Epilepsy
Using a genetic model known as Genetic Absence Epilepsy Rats of Strasbourg (GAERS), Yale researchers have identified the neuronal basis for absence epilepsy. Their findings were published Jan. 10 in Nature Communications. During absence epilepsy episodes, children experience brief staring spells, during which they temporarily lose consciousness. Absence seizures can be captured by abnormal rhythms on EEG recordings, but their neuronal cause has never before been identified.
Breakthrough Alzheimer's drug slows symptoms, possible approval on horizon
Christopher Van Dyck, MD, professor of psychiatry, neurology, and neuroscience; director, Alzheimer's Disease Research Unit; and director, division of aging and geriatric psychiatry, speaks about Lecanemab, a breakthrough medication that appears to slow the progression of Alzheimer's disease symptoms by almost 30%.Source: FOX61
Potential New Treatment for “Brain Fog” in Long COVID Patients
While the number of patients they studied is too small for their results to be definitive, Yale researchers—using their extensive experience with two existing medications—have published initial evidence that those drugs, given together, can mitigate or even eliminate brain fog.
Céline Dion has stiff person syndrome, a rare neurological disorder. What is that?
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Kunal Desai, MD, weigh in on the causes, symptoms, and treatments of SPS, as well as whether the neuromuscular condition affects lifespan.Source: USA Today
What is Stiff Person Syndrome?
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS, weigh in on the causes, symptoms, and treatment options for this neuromuscular condition, as well as whether or not if affects lifespan.Source: New York Times
What is stiff-person syndrome? Celine Dion reveals rare condition.
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists, including Yale assistant professor Kunal Desai, MD, weigh in on the neuromuscular condition's causes, symptoms, and treatment options, as well as whether the condition affects lifespan.Source: Washington Post
Celine Dion has stiff-person syndrome, a one-in-a-million diagnosis. These are its symptoms.
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS weigh in on the causes, symptoms, and treatments of this neuromuscular condition, as well as whether it affects lifespan.Source: NBC News
Study: Alzheimer's Drug Shows Modest Success Slowing Declines in Memory, Thinking
Christopher Van Dyck, MD, professor of psychiatry and director of the Alzheimer's Disease Research Unit, spoke about an experimental drug for Alzheimer's disease patients at the Clinical Trials on Alzheimer's Disease meeting in San Francisco in November.Source: NPR